Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 6/2010

01-12-2010 | Case Report

The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound

Authors: T. J. Albert, D. L. Stevens

Published in: Infection | Issue 6/2010

Login to get access

Abstract

Introduction

Severe human infections caused by the Pasteurella species are typically seen following animal bites. P. canis is a species that rarely affects humans and has never been found in systemic infections.

Summary

Here, we report the first documented case of P. canis bacteremia in an infected human, thought to be caused by a dog lick to an open leg wound.
Literature
1.
Palutke WA, Boyd CB, Carter GR. Pasteurella multocida septicemia in a patient with cirrhosis. Report of a case. Am J Med Sci. 1973;266(4):305–8.CrossRefPubMed
2.
Mutters R, Ihm P, Pohl S, Frederiksen W, Mannheim W. Reclassification of the genus Pasteurella Treevisan 1887 on the basis of the deoxyribonucleic acid homology, with proposals for the new species Pasteurella dagmatis, Pasteurella canis, Pasteurella stomatis, Pasteurella anatis, and Pasteurella langaa. Int J Syst Bacteriol. 1985;35:309–22.CrossRef
3.
Weber DJ, Wolfson JS, Swartz MN, Hooper DC. Pasteurella multocida infections. Report of 34 cases and review of the literature. Medicine (Baltimore). 1984;63(3):133–54.
4.
Talan DA, Citron DM, Abrahamian FM, Moran GJ, Goldstein EJ. Bacteriologic analysis of infected dog and cat bites. Emergency medicine animal bite infection study group. N Engl J Med. 1999;340(2):85–92.CrossRefPubMed
5.
Hubbert WT, Rosen MN. Pasteurella multocida infections. II. Pasteurella multocida infection in man unrelated to animal bite. Am J Public Health Nations Health. 1970;60(6):1109–17.CrossRefPubMed
6.
Raffi F, Barrier J, Baron D, Drugeon HB, Nicolas F, Courtieu AL. Pasteurella multocida bacteremia: report of thirteen cases over 12 years and review of the literature. Scand J Infect Dis. 1987;19(4):385–93.CrossRefPubMed
7.
Kumar A, Devlin HR, Vellend H. Pasteurella multocida meningitis in an adult: case report and review. Rev Infect Dis. 1990;12(3):440–8.PubMed
8.
Holst E, Rollof J, Larsson L, Nielsen JP. Characterization and distribution of Pasteurella species recovered from infected humans. J Clin Microbiol. 1992;30(11):2984–7.PubMed
9.
Donnio PY, Lerestif-Gautier AL, Avril JL. Characterization of Pasteurella spp. strains isolated from human infections. J Comp Pathol. 2004;130(2–3):137–42.CrossRefPubMed
10.
Ashley BD, Noone M, Dwarakanath AD, Malnick H. Fatal Pasteurella dagmatis peritonitis and septicaemia in a patient with cirrhosis: a case report and review of the literature. J Clin Pathol. 2004;57(2):210–2.CrossRefPubMed
11.
Rosenthal SL, Freundlich LF. In vitro antibiotic sensitivity of Pasteurella multocida. Health Lab Sci. 1976;13(4):246–9.PubMed
12.
Stevens DL, Higbee JW, Oberhofer TR, Everett ED. Antibiotic susceptibilities of human isolates of Pasteurella multocida. Antimicrob Agents Chemother. 1979;16(3):322–4.PubMed
13.
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373–406.CrossRefPubMed
14.
Citron DM, Warren YA, Fernandez HT, Goldstein MA, Tyrrell KL, Goldstein EJ. Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J Clin Microbiol. 2005;43(5):2485–8.CrossRefPubMed
15.
Collins FM. Mechanisms of acquired resistance to Pasteurella multocida infection: a review. Cornell Vet. 1977;67(1):103–38.PubMed
16.
Rosenau A, Labigne A, Escande F, Courcoux P, Philippon A. Plasmid-mediated ROB-1 beta-lactamase in Pasteurella multocida from a human specimen. Antimicrob Agents Chemother. 1991;35(11):2419–22.PubMed
17.
Naas T, Benaoudia F, Lebrun L, Nordmann P. Molecular identification of TEM-1 beta-lactamase in a Pasteurella multocida isolate of human origin. Eur J Clin Microbiol Infect Dis. 2001;20(3):210–3.CrossRefPubMed
Metadata
Title
The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound
Authors
T. J. Albert
D. L. Stevens
Publication date
01-12-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 6/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0040-1

Other articles of this Issue 6/2010

Infection 6/2010 Go to the issue

Clinical and Epidemiological Study

A pre- and postoperative bacteriological study of chronic suppurative otitis media

Clinical and Epidemiological Study

One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings

Images in Infection

Mediastinitis as a complication of central venous catheterization

Case Report

Surgical wound infection, tuboovarian abscess, and sepsis caused by Edwardsiella tarda: case reports and literature review

Correspondence

Periurethral abscess complicating gonococcal urethritis: case report and literature review

Correspondence

Post varicella disseminated intravascular coagulation and transient protein S deficiency in an otherwise healthy 6-year-old boy: a case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits